The FDA is expecting to receive many more applications for individualized treatments, both in its small-molecule drug and gene therapy divisions. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
